Posted in | News | Gold | Mining Business

Osisko Reports New February Record of Average Daily Gold Production

Osisko Mining Corporation (the "Company" or "Osisko") is pleased to report that directly following record quarterly production in Q4 2013 of 137,321 ounces gold, record annual production for 2013 of 475,277 ounces gold, and record monthly production for January 2014 of 50,111 ounces gold, Osisko's flagship Canadian Malartic mine has achieved record average daily gold production in the month of February.

Statistics for February are presented below:

  • Record average daily gold production of 1,648 ounces
  • Production of 46,154 ounces for the month of February
  • Monthly mill throughput of 1,492,582 tonnes
  • Average daily throughput of 53,307 tonnes per operational day
  • Average grade milled of 1.10 g/t Au
  • Average recovery of 87.7%

Since commencement of milling operations in April 2011, Canadian Malartic has produced 1,160,157 ounces of gold.

Sean Roosen, President and CEO of Osisko stated: "Canadian Malartic is certainly on record setting pace for 2014, and despite distractions faced by our team, they have again outdone themselves with record average daily gold production in the month of February. In our previous record month of January we achieved an average of 1,616 ounces of gold production per day. This new February record of 1,648 average daily ounces produced is a strong achievement for a short calendar month in the coldest part of the year. Canadian Malartic is an absolutely superb deposit with few equals in the world. This string of new records underscores the tremendous value to all shareholders of our strong cash flowing asset. I would like to remind shareholders of the unanimous recommendation of Osisko's Board of Directors to shareholders that you reject Goldcorp's inadequate hostile offer, and not to tender your shares to their bid".

Reject the Inadequate Goldcorp Offer

As previously disclosed, the Osisko Board of Directors has unanimously recommended that Osisko shareholders reject the hostile take-over bid initiated by Goldcorp and not tender their Osisko shares to the Goldcorp offer. The Osisko Board determined that the Goldcorp offer fails to adequately compensate Osisko shareholders for, among others things, the strategic value of Osisko's world-class asset base, the significant upside potential of Osisko's Canadian Malartic Mine, or the increased risk inherent in Goldcorp common shares. The full basis for the Osisko Board's recommendation is available in a Directors' Circular, a copy of which is available online at www.osisko.com.

Shareholders who have questions or who may have already tendered their shares to the Goldcorp Offer and wish to withdraw them, may do so by contacting our Information Agent, Laurel Hill Advisory Group at:
North American Toll Free: 1-877-452-7184
Banks, Brokers or collect calls: 416-304-2011
Email: [email protected]

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Osisko Gold Royalties Ltd. (2019, February 17). Osisko Reports New February Record of Average Daily Gold Production. AZoMining. Retrieved on November 23, 2024 from https://www.azomining.com/News.aspx?newsID=9507.

  • MLA

    Osisko Gold Royalties Ltd. "Osisko Reports New February Record of Average Daily Gold Production". AZoMining. 23 November 2024. <https://www.azomining.com/News.aspx?newsID=9507>.

  • Chicago

    Osisko Gold Royalties Ltd. "Osisko Reports New February Record of Average Daily Gold Production". AZoMining. https://www.azomining.com/News.aspx?newsID=9507. (accessed November 23, 2024).

  • Harvard

    Osisko Gold Royalties Ltd. 2019. Osisko Reports New February Record of Average Daily Gold Production. AZoMining, viewed 23 November 2024, https://www.azomining.com/News.aspx?newsID=9507.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.